Stay updated on TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing v3.4.1. No study content or page functionality appears to be affected.
    Difference
    0.1%
    Check dated 2026-02-17T04:08:15.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The page adds Revision: v3.4.1 and removes the earlier entries Revision: v3.4.0 and the government funding/operating-status notice.
    Difference
    0.4%
    Check dated 2026-02-10T01:14:22.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A government funding lapse notice has been added at the top of the page, informing users that information may not be up to date and directing them to cc.nih.gov and opm.gov for status updates.
    Difference
    0.4%
    Check dated 2026-02-02T21:38:48.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Additions include a 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' entry, 'No FEAR Act Data', and a 'Revision: v3.4.0' label. Deletions remove 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and the older 'Revision: v3.3.4' label.
    Difference
    0.2%
    Check dated 2026-01-26T19:49:37.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-19T14:25:15.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Locations section updated to include New York as a study site (New York, United States; Weill Cornell Medicine - New York Presbyterian Hospital). The old 'New York Locations' heading was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-22T01:48:08.000Z thumbnail image

Stay in the know with updates to TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TIL Therapy+Checkpoint Inhibitors in Metastatic Ovarian Cancer Clinical Trial page.